VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Conditions:   Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia Interventions:   Drug: Tamsulosin 0.2mg + Solifenacin 5mg;   Drug: Tamsulosin 0.2mg + Placebo(Solifenacin) Sponsor:   Jeil Pharmaceutical Co., Ltd. Recruiting - verified November 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2016 Category: Research Source Type: clinical trials

Clinical Trial to Compare the Solifenacin/Tamsulosin Combination Therapy With Tamsulosin Monotherapy for LUTS Due to BPH
Conditions:   Lower Urinary Tract Symptoms;   Benign Prostatic Hyperplasia Interventions:   Drug: Tamsulosin 0.2mg + Solifenacin 5mg;   Drug: Tamsulosin 0.2mg + Placebo(Solifenacin) Sponsor:   Jeil Pharmaceutical Co., Ltd. Recruiting - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2016 Category: Research Source Type: clinical trials